| Mr David Lu
| Mr David Lu is Financial Analyst at RBC Capital Markets. |
| Mr Matthew McConnell
| Mr Matthew McConnell is Financial Analyst at RBC Capital Markets. Mr McConnell holds CFA. |
| Mr Deane Dray
| Mr Deane Dray is Financial Analyst at RBC Capital Markets. Mr Sinha holds CFA. |
| Mr Krishna Sinha
| Mr Krishna Sinha is Financial Analyst at RBC Capital Markets. |
| Mr Steven Cahall
| Mr Steven Cahall is Financial Analyst at RBC Capital Markets. |
| Mr Robert Stallard
| Mr Robert Stallard is Financial Analyst at RBC Capital Markets. |
| Mr A. Eugene Washington
| Mr A. Eugene Washington is an Independent Director at Johnson and Johnson, Dr. Washington brings to our Board his distinct expertise born of significant achievements as a senior executive in academia, an accomplished clinical investigator, an innovator in health care, and a leader in shaping national health policy. With his unique combination of knowledge, skills and experience in organizational management, medical research, patient care, and public health policy, Dr. Washington provides an invaluable perspective for a company in the health care industry. Dr. Washington joined the Board of Directors in 2012 and is a member of the Compensation & Benefits Committee, and the Science, Technology & Sustainability Committee. Dr. Washington is currently Duke University's Chancellor for Health Affairs and the President and Chief Executive Officer of the Duke University Health System. Previously he was Vice Chancellor of Health Sciences, Dean of the David Geffen School of Medicine at UCLA; Chief Executive Officer of the UCLA Health System; and Distinguished Professor of Gynecology and Health Policy at UCLA. Prior to UCLA, he served as Executive Vice Chancellor and Provost at the University of California, San Francisco (UCSF) from 2004 to 2010. Dr. Washington co-founded UCSF's Medical Effectiveness Research Center for Diverse Populations in 1993 and served as the director until 2005. He was Chair of the Department of Obstetrics, Gynecology, and Reproductive Sciences at UCSF from 1996 to 2004. Dr. Washington also co-founded the UCSF-Stanford Evidence-based Practice Center and served as its first director from 1997 to 2002. |
| Mr Mark B. McClellan
| Mr Mark B. McClellan is Independent Director at Johnson and Johnson, joined the Board of Directors in 2013, and is a member of the Regulatory, Compliance & Government Affairs Committee, and the Science, Technology & Sustainability Committee. He currently is a Senior Fellow in Economic Studies, and Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution, which he joined in 2007, following a year as a visiting senior fellow at the American Enterprise Institute-Brookings Joint Center for Regulatory Studies. As former commissioner of the U.S. Food and Drug Administration from 2002 to 2004, and as the former administrator of the Centers for Medicare & Medicaid Services for the U.S. Department of Health and Human Services from 2004 to 2006, Dr. McClellan has more than two decades of public service and academic research experience. From 2001 to 2002, he served as a member of the President's Council of Economic Advisers and senior director for health care policy at the White House. During President William J. Clinton's administration, Dr. McClellan held the position of deputy assistant secretary of the Treasury for economic policy. Dr. McClellan previously served as an associate professor of economics and medicine with tenure at Stanford University, where he also directed the Program on Health Outcomes Research. |
| Mr Harsh Mehta
| Mr Harsh Mehta is a Financial Analyst at Goldman Sachs. |
| Mr Philip T. Ruegger
| Mr. Philip T. Ruegger III is Board Member at Travelers Companies Inc. Mr. Philip T. Ruegger, also known as Pete, III, has been a Partner of Simpson Thacher & Bartlett LLP since 1981. Mr. Ruegger joined Simpson Thacher in 1974. He served as an Administrative Partner of Simpson Thacher from 1993 to 1996. He served as the Chairman of Simpson Thacher & Bartlett LLP. He serves as a Director of The Partnership for New York City, Inc. He serves as a Trustee of Natural Resources Defense Council, Inc. He serves as a Member of the Association of the Bar of the City of New York. Mr. Ruegger holds an AB from Dartmouth College in 1971 and JD from the University of Virginia School of Law in 1974. |
| Mr Irwin R. Ettinger
| Mr. Irwin R. Ettinger is Vice Chairman at Travelers Companies Inc. Mr. Ettinger was previously employed as Vice Chairman by Travelers Property Casualty Corp., Chief Accounting & Tax Officer by Citigroup, Inc., and Partner by Arthur Young & Co. Mr. Ettinger served as the Chief Accounting and Tax Officer for Citigroup from 1998 to May 2002 and held other positions of increasing responsibility since joining Citigroup in 1987. Mr. Ettinger joined Citigroup from Arthur Young & Co. (now Ernst & Young), where he was a Partner for 18 years. He serves as a Member of the Advisory Council of the Weissmen Center for International Business of Baruch College of the City University of New York and is a Member of the Executive Committee of the Baruch College Fund. |
| Mr Merrill Lynch Research Team
| Merrill Lynch Research Team is staffed by a dedicated analyst team which focuses on delivering detailed investment analysis of equity at Merrill Lynch. |
| Mr Marc Parr
| Mr Marc Parr is Director Investor Relations at Travelers since June 2002. |
| Ms Gabriella Nawi
| Ms Gabriella Nawi is Head of Investor Relations at Travelers Insurance since July 2008. She has studied at Wesleyan University from 1987 to1990. |
| Ms Nancy Paxton
| Ms Nancy Paxton is the Contact Person at Apple Inc. Ms Paxton is Senior Investor Relations and Treasury at Apple Inc. |
| Mr Eric Sagmeister
| Mr. Eric Sagmeister is a Manager of Select EM Dividend - Class C |
| Mr Bruce R. Brewington
| Mr. Bruce R. Brewington is a Manager of Select EM Dividend - Advisor Class |
| Mr Randall T. Coleman
| Mr. Randall T. Coleman is a Manager of Select EM Dividend - Investor Class |
| Mr David L. Ruff
| Mr. David L. Ruff is a Manager of Select EM Dividend - Institutional Class |
| Mr Jim O’Donnell
| Mr. Jim O’Donnell is a Manager of Frontier Strategy - Advisor Class. |
